Acadian Asset Management LLC Sells 5,995 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Acadian Asset Management LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.0% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 69,338 shares of the healthcare conglomerate’s stock after selling 5,995 shares during the period. Acadian Asset Management LLC’s holdings in UnitedHealth Group were worth $34,290,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. BKM Wealth Management LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $2,016,000. Etesian Wealth Advisors Inc. raised its position in UnitedHealth Group by 2.2% in the 4th quarter. Etesian Wealth Advisors Inc. now owns 980 shares of the healthcare conglomerate’s stock valued at $514,000 after buying an additional 21 shares during the last quarter. Insight Wealth Strategies LLC grew its stake in shares of UnitedHealth Group by 1.4% during the 4th quarter. Insight Wealth Strategies LLC now owns 5,423 shares of the healthcare conglomerate’s stock worth $2,855,000 after acquiring an additional 76 shares in the last quarter. My Legacy Advisors LLC boosted its holdings in UnitedHealth Group by 1.6% during the fourth quarter. My Legacy Advisors LLC now owns 6,131 shares of the healthcare conglomerate’s stock worth $3,309,000 after purchasing an additional 97 shares during the last quarter. Finally, Fortitude Family Office LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $135,000. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Argus upped their target price on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Morgan Stanley upped their target price on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Barclays boosted their price target on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, Truist Financial boosted their price target on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $614.17.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

NYSE UNH traded down $7.11 on Monday, hitting $558.22. 2,075,793 shares of the stock traded hands, compared to its average volume of 4,338,922. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $581.50. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.85 and a current ratio of 0.88. The business’s fifty day moving average is $504.56 and its two-hundred day moving average is $500.44. The firm has a market capitalization of $513.78 billion, a price-to-earnings ratio of 34.26, a PEG ratio of 1.66 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter last year, the company earned $6.14 earnings per share. The company’s revenue was up 6.4% on a year-over-year basis. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date was Monday, June 17th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.